ABOUT / EDITORIAL METHOD
A Repair Digest With Little Patience for Wishful Thinking
An independent reading desk for a field where mechanistic plausibility routinely arrives before adequate human evidence.
What this site is
Peachy Peptides is an independent literature digest focused on Recovery & Tissue Repair research peptides. It is not a clinic, vendor, product catalog, or dosing guide. The editorial frame is deliberately narrow: skin texture and barrier-repair signals, with every appearance outcome kept attached to the model and study that produced it.
The hub covers GHK-Cu, BPC-157, and the GLOW research blend because they illustrate three recurring evidence patterns. GHK-Cu has limited topical human observations plus extensive mechanistic work. BPC-157 has a conspicuous preclinical repair record and almost no persuasive human efficacy evidence [7]. GLOW combines separate mechanisms without a controlled trial of the blend [13]. Reading them together makes the hierarchy easier to see than reading promotional summaries one at a time.
How to read the pages
Each technical page begins with a plain-language summary, then separates identity, mechanism, findings, reported effects, cautions, and thematic fit. Bracketed numbers point to the shared reference ledger. A citation supports the nearby claim; it does not endorse every conclusion on the page. Human skin, isolated skin, a rat tendon, cultured endothelial cells, and a narrative review answer different questions.
Quantitative findings remain tied to sources. Community reports are labeled anecdotal, not clinical evidence because uncontrolled accounts cannot establish cause, effect size, or frequency. Mechanistic cautions are identified as theoretical when human harm has not been demonstrated. Absence of a reported adverse event in a tiny sample is not proof of safety.
The editorial stance
This desk starts with what is not established. It then asks whether the remaining evidence is direct, replicated, and relevant. Human controlled outcomes carry more weight than animal models. Animal models carry more weight than an isolated pathway. A tested formulation carries more weight than inference from an ingredient list. A blend must earn its own evidence.
The stance is skeptical, not dismissive. GHK-Cu has a plausible and partly observed topical skin signal [1][4]. BPC-157 has repair biology worth studying [9][10][11]. The GLOW combination offers a coherent hypothesis. None of those sentences needs to become a promise. Confidence is allowed to remain low when study design demands it.
Scope and revision
The pages summarize the composed reference corpus listed on this site. They do not diagnose conditions, recommend treatments, compare vendors, or provide human protocols. The absence of purchasing guidance is intentional. The scientific question is what a defined material did under stated study conditions, not where an unverified product can be obtained. Editorial independence also means that a compelling compound name, enthusiastic community, or fashionable mechanism earns no extra evidentiary weight.
Research changes. A future controlled trial could strengthen, narrow, or contradict this account. Until then, Peachy Peptides favors traceable restraint: identify the molecule, name the model, report the outcome, and stop at the edge of the data.